Literature DB >> 21577038

Management of retinal vein occlusion--consensus document.

Gabriel Coscas1, Anat Loewenstein, Albert Augustin, Francesco Bandello, Maurizio Battaglia Parodi, Paolo Lanzetta, Jordi Monés, Marc de Smet, Gisèle Soubrane, Giovanni Staurenghi.   

Abstract

Retinal vein occlusion (RVO) can have severe consequences for the people affected by the disease, including visual loss with costly social repercussions. Currently, there is no European consensus with regard to the management of RVO. Following a careful review of the medical literature as well as the data from several clinical trials, a collaborative group of retina specialists put forth practical recommendations based on the best available scientific evidence for the clinical approach to RVO. Taking into consideration the recent advances in diagnostic tools and management options, the present document aims to provide the European ophthalmologists with guidelines for clinical practice to the benefit of their patients.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21577038     DOI: 10.1159/000327391

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  32 in total

1.  Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.

Authors:  Julie Blanc; Clémence Deschasse; Laurent Kodjikian; Corinne Dot; Alain-Marie Bron; Catherine Creuzot-Garcher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-31       Impact factor: 3.117

2.  Optical coherence tomography angiography in retinal vein occlusions.

Authors:  Qian Wang; Szy Yann Chan; Yanni Yan; Jingyan Yang; Wenjia Zhou; Jost B Jonas; Wen Bin Wei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

3.  Angiography reveals early hiding iris neovascularization after ischemic CRVO.

Authors:  Zhi-Qing Li; Xiao-Xu Zhou; Song Lin; Jun-Ling Li; Jian-Guo Wu
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

4.  Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion.

Authors:  Yoav Y Pikkel; Adi Sharabi-Nov; Itzchak Beiran; Joseph Pikkel
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

5.  Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion.

Authors:  Ivana Gardašević Topčić; Maja Šuštar; Jelka Brecelj; Marko Hawlina; Polona Jaki Mekjavić
Journal:  Doc Ophthalmol       Date:  2014-06-07       Impact factor: 2.379

6.  Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.

Authors:  C Chiquet; C Dupuy; A M Bron; F Aptel; M Straub; R Isaico; J P Romanet; C Creuzot-Garcher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-12       Impact factor: 3.117

7.  [Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

Authors:  M Rehak; E Spies; M Scholz; P Wiedemann
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

8.  Update in the Management of Macular Edema Following Retinal Vein Occlusions.

Authors:  Mariana R Thorell; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2016-03-10

9.  Biomarkers of Peripheral Nonperfusion in Retinal Venous Occlusions Using Optical Coherence Tomography Angiography.

Authors:  Diogo Cabral; Florence Coscas; Agnes Glacet-Bernard; Telmo Pereira; Carlos Geraldes; Francisco Cachado; Ana Papoila; Gabriel Coscas; Eric Souied
Journal:  Transl Vis Sci Technol       Date:  2019-05-02       Impact factor: 3.283

10.  Optical coherence tomographic patterns in patients with retinal vein occlusion and macular edema treated by ranibizumab: a predictive and personalized approach.

Authors:  D Yu Khokhlova; E A Drozdova; N I Kurysheva; I A Loskutov
Journal:  EPMA J       Date:  2021-03-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.